Goran Bajic

Assistant Professor

Icahn School of Medicine at Mount Sinai

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Goran Bajic is an Assistant Professor at the Icahn School of Medicine at Mount Sinai in the United States. His research focuses on immunology, particularly the interactions between human antibodies and influenza virus hemagglutinin, as well as responses to SARS-CoV-2. Recent articles authored by Dr. Bajic explore various aspects of antibody recognition, vaccination efficacy, and the evolution of viral variants in relation to immune response.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

Felipe Lelis

Head of R&D

Pulse Biosciences

UNITED STATES

View details

Chen-Hao Yeh

Assistant Professor

Duke University

UNITED STATES

View details

Juan Manuel Carreno Quiroz

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Randy Albrecht

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Goran Bajic

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies

Human naïve B cells recognize prepandemic influenza virus hemagglutinins

Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk-Directed Antibody Response.

Infant Antibody Repertoires during the First Two Years of Influenza Vaccination.

Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain

Recall of B cell memory depends on relative locations of prime and boost immunization

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.

Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.

A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.

A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.

Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike

Collaborators (10)

Garnett Kelsoe

Jiwon Lee

Anna Honko

Teresa Allende Aydillo Gomez

Shengli Song

Yiren Qin

Felipe Lelis

Chen-Hao Yeh

Juan Manuel Carreno Quiroz

Randy Albrecht

Make your next move.